Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival

Bioscience Reports

Volumn 32, Issue 1, 2012, Pages 91-104

  Kumar, Anjani ^a   Vishvakarma, Naveen Kumar ^a   Tyagi, Abhishek ^b   Bharti, Alok Chandra ^b   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Apoptosis; Aspirin; Dalton's lymphoma; T cell lymphoma; Tumour microenvironment

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE; CANCER GROWTH FACTOR; CANCER GROWTH FACTOR BETA; CYCLIN B1; GAMMA INTERFERON; GLUCOSE; GLUCOSE TRANSPORTER 1; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1; NITRIC OXIDE; OXYGEN; PUMA PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 5; SURVIVIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG RESPONSE; G0 PHASE CELL CYCLE CHECKPOINT; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATOR GENE; T CELL LYMPHOMA; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; ASPIRIN; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CYCLIN B1; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRALESIONAL; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; LACTIC ACID; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

MURINAE; MUS;

EID: 84863010982     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20110027     Document Type: Article

References (55)

1. Amann, R. and Peskar, B. A. (2002) Anti-inflammatory effects of aspirin and sodium salicylate. Eur. J. Pharmacol. 447, 1-9 (Pubitemid 34775215)
2. Cheng, I., Liu, X., Plummer, S. J., Krumroy, L. M., Casey, G. and Witte, J. S. (2007) COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br. J. Cancer 97, 557-561 (Pubitemid 47258446)
3. Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A. and Morgan, G. (2009) Aspirin, salicylates, and cancer. Lancet 373, 1301-1309
4. de Groot, D. J., de Vries, E. G., Groen, H. J. and de Jong, S. (2007) Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit. Rev. Oncol. Hematol. 61, 52-69 (Pubitemid 44880148)
5. Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A. et al. (2003) A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348, 891-899 (Pubitemid 36297997)
6. Bellosillo, B., Pique, M., Barragan, M., Castano, E., Villamor, N., Colomer, D., Montserrat, E., Pons, G. and Gil, J. (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92, 1406-1414 (Pubitemid 28369055)
7. Dihlmann, S., Klein, S. and Doeberitz Mv, M. K. (2003) Reduction of β-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated β-catenin. Mol. Cancer Ther. 2, 509-516
8. Dikshit, P., Chatterjee, M., Goswami, A., Mishra, A. and Jana, N. R. (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J. Biol. Chem. 281, 29228-29235 (Pubitemid 44507066)
9. Elder, D. J., Hague, A., Hicks, D. J. and Paraskeva, C. (1996) Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumour cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res. 56, 2273-2276
10. McCarty, M. F. and Block, K. I. (2006) Preadministration of high-dose salicylates, suppressors of NF-κB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy. Integr. Cancer Ther. 5, 252-268
11. Cha, Y. I. and DuBois, R. N. (2007) NSAIDs and cancer prevention: targets downstream of COX-2. Annu. Rev. Med. 58, 239-252 (Pubitemid 46706512)
12. Lopez, J. M., Fernandez, M. A., Pique, M. and Gil, J. (2004) Aspirin-induced apoptosis in Jurkat cells is not mediated by peroxisome proliferator-activated receptor delta. Mol. Cell Biochem. 266, 57-63 (Pubitemid 39562307)
13. Iglesias-Serret, D., Pique, M., Barragan, M., Cosialls, A. M., Santidrian, A. F., Gonzalez-Girones, D. M., Coll-Mulet, L., de Frias, M., Pons, G. and Gil, J. (2010) Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis 15, 219-229
14. Kopp, E. and Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265, 956-959
15. Armitage, J. O., Vose, J. M. and Weisenburger, D. D. (2004) Towards understanding the peripheral T-cell lymphomas. Ann. Oncol. 15, 1447-1449 (Pubitemid 39409731)
16. Ben-Efraim, S. (1999) One hundred years of cancer immunotherapy: a critical appraisal. Tumour Biol. 20, 1-24
17. Bharti, A. C. and Singh, S. M. (2003) Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T cell lymphoma: the involved mechanisms. Nitric Oxide 8, 75-82 (Pubitemid 36263435)
18. Singh, V. and Singh, S. M. (2009) Progressive tumour growth-associated altered tumour microenvironment: implications in a tumour stage-dependent modulation in survival of a murine T cell lymphoma. J. Cancer Res. Clin. Oncol. 135, 1015-1024
19. Singh, V. and Singh, S. M. (2009) A tumour stage-dependent evolution of drug resistant T cell lymphoma: role of soluble mediators of tumour and host origin. Leuk. Res. 33, 700-709
20. Verma, V. K., Singh, V., Singh, M. P. and Singh, S. M. (2010) Treadmill exercise-dependent tumour growth retardation in T-cell lymphoma-bearing host displays gender dimorphism. Oncol. Res. 18, 293-304
21. Vishvakarma, N. K. and Singh, S. M. (2011) Mechanisms of tumour growth retardation by modulation of pH regulation in the tumour-microenvironment of a murine T cell lymphoma. Biomed. Pharmacother. 65, 27-39
22. Vishvakarma, N. K. and Singh, S. M. (2010) Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in anti-tumour activation of tumour-associated macrophages. Immunol. Lett. 134, 83-92
23. Mahmoud, N. N., Dannenberg, A. J., Mestre, J., Bilinski, R. T., Churchill, M. R., Martucci, C., Newmark, H. and Bertagnolli, M. M. (1998) Aspirin prevents tumours in a murine model of familial adenomatous polyposis. Surgery 124, 225-231 (Pubitemid 28372920)
24. Paul-Clark, M. J., Van Cao, T., Moradi-Bidhendi, N., Cooper, D. and Gilroy, D. W. (2004) 15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69-78 (Pubitemid 38924729)
25. Papadopulos, F., Spinelli, M., Valente, S., Foroni, L., Orrico, C., Alviano, F. and Pasquinelli, G. (2007) Common tasks in microscopic and ultrastructural image analysis using ImageJ. Ultrastruct. Pathol. 31, 401-407
26. Grigoryev, S. A., Nikitina, T., Pehrson, J. R., Singh, P. B. and Woodcock, C. L. (2004) Dynamic relocation of epigenetic chromatin markers reveals an active role of constitutive heterochromatin in the transition from proliferation to quiescence. J. Cell Sci. 117, 6153-6162 (Pubitemid 40123979)
27. Somoza, B., Guzman, R., Cano, V., Merino, B., Ramos, P., Diez-Fernandez, C., Fernandez-Alfonso, M. S. and Ruiz-Gayo, M. (2007) Induction of cardiac uncoupling protein-2 expression and adenosine 5′-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice. Endocrinology 148, 924-931
28. Bharti, A. C., Donato, N., Singh, S. and Aggarwal, B. B. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062 (Pubitemid 36139379)
29. Garber, K. (2004) Aspirin for cancer chemoprevention: still a headache? J. Natl. Cancer Inst. 96, 252-253
30. Ikonomidis, I., Andreotti, F., Economou, E., Stefanadis, C., Toutouzas, P. and Nihoyannopoulos, P. (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100, 793-798 (Pubitemid 29398875)
31. Cowpe, J. G. (1984) Quantitative exfoliative cytology of normal and abnormal oral mucosal squames: preliminary communication. J. R. Soc. Med. 77, 928-931
32. Frost, A. (1997) Pathologic processes affecting cells from inflammation to cancer. In Comprehensive Cytopathology, 2nd edn (Bibbo, M., ed.), p. 845, W. B. Saunders, Philadelphia
33. Porter, L. A., Cukier, I. H. and Lee, J. M. (2003) Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood 101, 1928-1933 (Pubitemid 36237595)
34. Gao, C. Y. and Zelenka, P. S. (1995) Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells. Exp. Cell Res. 219, 612-618
35. Porter, L. A., Singh, G. and Lee, J. M. (2000) Abundance of cyclin B1 regulates γ-radiation-induced apoptosis. Blood 95, 2645-2650 (Pubitemid 30210545)
36. Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier, H. and Fotedar, A. (1995) Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol. Cell. Biol. 15, 932-942
37. Shimizu, T., O'Connor, P. M., Kohn, K. W. and Pommier, Y. (1995) Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55, 228-231
38. Oikawa, S., Kobayashi, H., Tada-Oikawa, S., Isono, Y. and Kawanishi, S. (2009) Damage to cellular and isolated DNA induced by a metabolite of aspirin. Mutat. Res. 661, 93-100
39. Folkman, J. and Moscona, A. (1978) Role of cell shape in growth control. Nature 273, 345-349 (Pubitemid 8344174)
40. Singhvi, R., Kumar, A., Lopez, G. P., Stephanopoulos, G. N., Wang, D. I., Whitesides, G. M. and Ingber, D. E. (1994) Engineering cell shape and function. Science 264, 696-698 (Pubitemid 24185878)
41. Bissell, M. J., Farson, D. and Tung, A. S. (1977) Cell shape and hexose transport in normal and virus-transformed cells in culture. J. Supramol. Struct. 6, 1-12 (Pubitemid 8179644)
42. Weber, A., Hengge, U. R., Stricker, I., Tischoff, I., Markwart, A., Anhalt, K., Dietz, A., Wittekind, C. and Tannapfel, A. (2007) Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum. Pathol. 38, 228-238 (Pubitemid 46096547)
43. Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H., Yoshida, Y., Tanabe, M., Ise, T., Murakami, T., Yoshida, T., Nomoto, M. and Kohno, K. (2003) Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat. Rev. 29, 541-549 (Pubitemid 37428326)
44. Spitz, G. A., Furtado, C. M., Sola-Penna, M. and Zancan, P. (2009) Acetylsalicylic acid and salicylic acid decrease tumour cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem. Pharmacol. 77, 46-53
45. Rastogi, S., Banerjee, S., Chellappan, S. and Simon, G. R. (2007) Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. Cancer Lett. 257, 244-251 (Pubitemid 47538826)
46. Behrooz, A. and Ismail-Beigi, F. (1997) Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation. J. Biol. Chem. 272, 5555-5562 (Pubitemid 27102379)
47. Chiche, J., Ilc, K., Laferriere, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C. and Pouyssegur, J. (2009) Hypoxia-inducible carbonic anhydrase IX and XII promote tumour cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358-368
48. Lopez-Lazaro, M. (2006) HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? FASEB J. 20, 828-832
49. Diez, I., Calatayud, S., Hernandez, C., Quintana, E., O'Connor, J. E., Esplugues, J. V. and Barrachina, M. D. (2010) Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1α in macrophages during aspirin-induced mesenteric inflammation Br. J. Pharmacol. 159, 1636-1645
50. Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Nakagawa, R., Fukuyama, H., Nagata, S. and Kishimoto, T. (2000) Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumour necrosis factor α-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 97, 5405-5410 (Pubitemid 30313731)
51. Alas, S., Emmanouilides, C. and Bonavida, B. (2001) Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin. Cancer Res. 7, 709-723 (Pubitemid 32707998)
52. Sun, Q. H., Peng, J. P. and Xia, H. F. (2006) IFNγ pretreatment sensitizes human choriocarcinoma cells to etoposide-induced apoptosis. Mol. Hum. Reprod. 12, 99-105
53. Wang, P., Qiu, W., Dudgeon, C., Liu, H., Huang, C., Zambetti, G. P., Yu, J. and Zhang, L. (2009) PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis. Cell Death Differ. 16, 1192-1202
54. Grinwich, K. D. and Plescia, O. J. (1977) Tumour-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis. Prostaglandins 14, 1175-1182 (Pubitemid 8260085)
55. Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M. and Dubinett, S. M. (1999) T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J. Immunol. 163, 5020-5028 (Pubitemid 29501270)